Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space
AG Schwaid, KB Spencer - Journal of Medicinal Chemistry, 2020 - ACS Publications
Inhibiting the NLRP3 inflammasome mediates inflammation in an extensive number of
preclinical models. As excitement in this field has grown, several companies have recently …
preclinical models. As excitement in this field has grown, several companies have recently …
Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space
AG Schwaid, KB Spencer - Journal of medicinal chemistry, 2021 - pubmed.ncbi.nlm.nih.gov
Inhibiting the NLRP3 inflammasome mediates inflammation in an extensive number of
preclinical models. As excitement in this field has grown, several companies have recently …
preclinical models. As excitement in this field has grown, several companies have recently …
[引用][C] Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space
AG Schwaid, KB Spencer - Journal of Medicinal Chemistry, 2020 - cir.nii.ac.jp
Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space.
AG Schwaid, KB Spencer - Journal of Medicinal Chemistry, 2020 - europepmc.org
Inhibiting the NLRP3 inflammasome mediates inflammation in an extensive number of
preclinical models. As excitement in this field has grown, several companies have recently …
preclinical models. As excitement in this field has grown, several companies have recently …